Atlas Trials

Effects of Dexmedetomidine in Patients With Agitated Delirium in Palliative Care

Clinical trial NCT04824144 · RECRUITING

Trial details

NCT number
NCT04824144
Sponsor
Bruyère Health Research Institute.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hyperactive DeliriumDelirium of Mixed Origin
Start date
2024-01-30
Primary completion
2026-01-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.